Laponis Adam
Laponis Adam, CFO, reported an open-market or private sale at Twist Bioscience Corp involving 2462.000000 shares for an estimated $384822.66. Reported holdings after the transaction were 98114.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Oct 09, 2026
- Filing date
- Oct 13, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 100,576 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
TWST price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001214659-26-012823 Common Stock
- Transaction date
- Oct 09, 2026 Filed Oct 13, 2026, 08:05 PM · 4d delay
- Shares
- 2,462 sh $156.30 per share
- Estimated value
- -$384k Computed from shares × price
- Holdings after
- 98,114 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+6 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Financial Officer
- F1
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by t…
0 other transactions
0 recent txs